Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × venetoclax × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 61 Leukemia, Lymphocytic, Chronic, B-Cell 23 Myelodysplastic Syndromes 17 Leukemia 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 6 Leukemia, Myelomonocytic, Chronic 6 Hematologic Neoplasms 6 Burkitt Lymphoma 6 Recurrence 5 Myeloproliferative Disorders 5 Leukemia, Biphenotypic, Acute 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, B-Cell, Marginal Zone 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Waldenstrom Macroglobulinemia 2 Multiple Myeloma 2 Leukemia, Myeloid 2 Immunoglobulin Light-chain Amyloidosis 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Anemia, Refractory, with Excess of Blasts 2 Venentoclax 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Sarcoma, Myeloid 1 Primary Myelofibrosis 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 2 trametinib 1 liposomal doxorubicin 1 fludarabine phosphate 1 fludarabine 1 dabrafenib 1 Zidovudine 1 Whole-Body Irradiation 1 Vincristine 1 Valganciclovir 1 Tacrolimus 1 Sirolimus 1 Rituximab 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Busulfan 1 Bortezomib 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡